157 related articles for article (PubMed ID: 17140253)
1. Macrophage-targeted photosensitizer conjugate delivered by intratumoral injection.
Anatelli F; Mroz P; Liu Q; Yang C; Castano AP; Swietlik E; Hamblin MR
Mol Pharm; 2006; 3(6):654-64. PubMed ID: 17140253
[TBL] [Abstract][Full Text] [Related]
2. Pegylation of a chlorin(e6) polymer conjugate increases tumor targeting of photosensitizer.
Hamblin MR; Miller JL; Rizvi I; Ortel B; Maytin EV; Hasan T
Cancer Res; 2001 Oct; 61(19):7155-62. PubMed ID: 11585749
[TBL] [Abstract][Full Text] [Related]
3. Photosensitizer delivery to vulnerable atherosclerotic plaque: comparison of macrophage-targeted conjugate versus free chlorin(e6).
Tawakol A; Castano AP; Anatelli F; Bashian G; Stern J; Zahra T; Gad F; Chirico S; Ahmadi A; Fischman AJ; Muller JE; Hamblin MR
J Biomed Opt; 2006; 11(2):021008. PubMed ID: 16674183
[TBL] [Abstract][Full Text] [Related]
4. Macrophage-targeted photodynamic therapy: scavenger receptor expression and activation state.
Liu Q; Hamblin MR
Int J Immunopathol Pharmacol; 2005; 18(3):391-402. PubMed ID: 16164823
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of Radachlorin(R) sensitizer for photodynamic therapy.
Douillard S; Olivier D; Patrice T
Photochem Photobiol Sci; 2009 Mar; 8(3):405-13. PubMed ID: 19255683
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic efficacy of topical application of chlorin e6--polyvinyl pyrrolidone complex in tumor-bearing rats.
Istoin YP; Laptsevich TP; Bizyuk SA; Alexandrova EN
Exp Oncol; 2006 Dec; 28(4):299-302. PubMed ID: 17285114
[TBL] [Abstract][Full Text] [Related]
7. Scavenger-receptor targeted photodynamic therapy.
Hamblin MR; Miller JL; Ortel B
Photochem Photobiol; 2000 Oct; 72(4):533-40. PubMed ID: 11045726
[TBL] [Abstract][Full Text] [Related]
8. Receptor-mediated targeting of phthalocyanines to macrophages via covalent coupling to native or maleylated bovine serum albumin.
Brasseur N; Langlois R; La Madeleine C; Ouellet R; van Lier JE
Photochem Photobiol; 1999 Mar; 69(3):345-52. PubMed ID: 10089827
[TBL] [Abstract][Full Text] [Related]
9. Selective targeting and photodynamic destruction of intimal hyperplasia by scavenger-receptor mediated protein-chlorin e6 conjugates.
Nagae T; Louie AY; Aizawa K; Ishimaru S; Wilson SE
J Cardiovasc Surg (Torino); 1998 Dec; 39(6):709-15. PubMed ID: 9972886
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of photodynamic therapy with a novel targeted photosensitizer on cervical carcinoma.
Li PX; Mu JH; Xiao HL; Li DH
Oncol Rep; 2015 Jan; 33(1):125-32. PubMed ID: 25376180
[TBL] [Abstract][Full Text] [Related]
11. Functional long circulating single walled carbon nanotubes for fluorescent/photoacoustic imaging-guided enhanced phototherapy.
Xie L; Wang G; Zhou H; Zhang F; Guo Z; Liu C; Zhang X; Zhu L
Biomaterials; 2016 Oct; 103():219-228. PubMed ID: 27392290
[TBL] [Abstract][Full Text] [Related]
12. Improved targeting of photosensitizers by intratumoral administration of immunoconjugates.
Gupta S; Mishra AK; Muralidhar K; Jain V
Technol Cancer Res Treat; 2004 Jun; 3(3):295-301. PubMed ID: 15161322
[TBL] [Abstract][Full Text] [Related]
13. Chlorin e6 combined with albumin nanoparticles as a potential composite photosensitizer for photodynamic therapy of tumors.
Shton IO; Sarnatskaya VV; Prokopenko IV; Gamaleia NF
Exp Oncol; 2015 Dec; 37(4):250-4. PubMed ID: 26710836
[TBL] [Abstract][Full Text] [Related]
14. Microscopic analysis of the localization of two chlorin-based photosensitizers in OSC19 tumors in the mouse oral cavity.
van Leeuwen-van Zaane F; van Driel PB; Gamm UA; Snoeks TJ; de Bruijn HS; van der Ploeg-van den Heuvel A; Löwik CW; Sterenborg HJ; Amelink A; Robinson DJ
Lasers Surg Med; 2014 Mar; 46(3):224-34. PubMed ID: 24436109
[TBL] [Abstract][Full Text] [Related]
15. Fullerene/photosensitizer nanovesicles as highly efficient and clearable phototheranostics with enhanced tumor accumulation for cancer therapy.
Guan M; Ge J; Wu J; Zhang G; Chen D; Zhang W; Zhang Y; Zou T; Zhen M; Wang C; Chu T; Hao X; Shu C
Biomaterials; 2016 Oct; 103():75-85. PubMed ID: 27376559
[TBL] [Abstract][Full Text] [Related]
16. Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model.
Ferrario A; Kessel D; Gomer CJ
Cancer Res; 1992 May; 52(10):2890-3. PubMed ID: 1581904
[TBL] [Abstract][Full Text] [Related]
17. Studies on preparation and photodynamic mechanism of chlorin P6-13,15-N-(cyclohexyl)cycloimide (Chlorin-H) and its antitumor effect for photodynamic therapy in vitro and in vivo.
Yan YJ; Zheng MZ; Chen ZL; Yu XH; Yang XX; Ding ZL; Xu L
Bioorg Med Chem; 2010 Sep; 18(17):6282-91. PubMed ID: 20691601
[TBL] [Abstract][Full Text] [Related]
18. Scavenger-receptor-mediated delivery of daunomycin elicits selective toxicity towards neoplastic cells of macrophage lineage.
Mukhopadhyay A; Mukhopadhyay B; Srivastava RK; Basu SK
Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):237-41. PubMed ID: 1599401
[TBL] [Abstract][Full Text] [Related]
19. The potential application of chlorin e6-polyvinylpyrrolidone formulation in photodynamic therapy.
Chin WW; Heng PW; Bhuvaneswari R; Lau WK; Olivo M
Photochem Photobiol Sci; 2006 Nov; 5(11):1031-7. PubMed ID: 17077899
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional trastuzumab-chlorin e6 conjugate for the treatment of HER2-positive human breast cancer.
Kim KS; Kim J; Kim DH; Hwang HS; Na K
Biomater Sci; 2018 May; 6(5):1217-1226. PubMed ID: 29578555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
